Related Experiment Videos
[Serum complement levels in patients with rheumatoid arthritis and vasculitis]
Fukuoka Igaku Zasshi = Hukuoka Acta Medica
|October 1, 1989
Summary
Malignant rheumatoid arthritis (MRA) shows decreased complement levels, particularly via the classical pathway, unlike uncomplicated rheumatoid arthritis. This suggests increased complement consumption contributes to MRA pathogenesis.
Area of Science:
- Immunology
- Rheumatology
- Biochemistry
Context:
- Rheumatoid arthritis (RA) can present with vasculitis, termed malignant rheumatoid arthritis (MRA).
- Understanding complement system alterations is crucial in autoimmune diseases like RA and systemic lupus erythematosus (SLE).
- Previous studies indicate decreased serum complement levels in MRA patients.
Purpose:
- To compare complement profiles in MRA patients with those in uncomplicated RA and SLE.
- To investigate the role of complement activation and regulation in MRA.
Summary:
- MRA patients exhibited decreased serum CH50, C4, and C3 levels, alongside elevated C3d and C3d/C3 ratio, indicating complement activation.
- Serum B levels were increased, while alternative pathway activity (AH50) remained normal.
- Elevated regulatory proteins (H and I), increased circulating immune complexes (CIC), and decreased immune complex solubilizing activity (CRA) were observed in MRA.
- Findings suggest significant complement consumption, primarily through the classical pathway, characterizes MRA.
Impact:
- These findings elucidate the specific complement dysregulation in MRA, differentiating it from RA and SLE.
- Provides insights into potential therapeutic targets related to complement pathways in MRA.
- Contributes to a deeper understanding of the immunopathology of severe rheumatoid arthritis manifestations.